Published December 2019
| Version v1
Journal article
[Pathogenesis of non-alcoholic fatty liver disease].
Creators
Contributors
Others:
- Centre méditerranéen de médecine moléculaire (C3M) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UniCA)
- Département Digestif ; Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital de l'Archet
- ANR-15-CE14-0016,HEPAMETOL,INTERACTION ENTRE ALCOOL ET L'OBÉSITÉ DANS LA SÉVÉRITÉ DES MALADIES DU FOIE GRAS.(2015)
- ANR-18-CE14-0019,INFLAMMASYK,Etude de la signalisation SYK dans les maladies inflammatoires chroniques(2018)
- ANR-11-LABX-0028,SIGNALIFE,Réseau d'Innovation sur les Voies de Signalisation en Sciences de la Vie(2011)
- ANR-15-IDEX-0001,UCA JEDI,Idex UCA JEDI(2015)
Description
Non-Alcoholic Fatty Liver Disease (NAFLD) is a complex chronic disease resulting from an interaction between genetic and environmental factors. The phenotype and pathophysiology of NAFLD is heterogeneous. NAFLD is a continuum of histological lesions of the liver from steatosis, Non-Alcoholic SteatoHepatitis (NASH), NASH with fibrosis, cirrhosis to hepatocellular carcinoma. The pathophysiology encompasses a dysfunction in fatty tissue (sub-cutaneous and visceral) associated with insulin-resistance and metabolic inflammation. NAFLD is a "multi-systemic" disease. Reciprocal and aggravating interactions exist between NAFLD, cardiovascular anomalies and diabetes. The understanding of the mechanisms responsible for NAFLD allows the identification of potential novel therapeutic targets.
Abstract
International audienceAdditional details
Identifiers
- URL
- https://hal.science/hal-04496691
- URN
- urn:oai:HAL:hal-04496691v1
Origin repository
- Origin repository
- UNICA